Search
Now showing items 11-20 of 25
Atrial fibrillation and future risk of venous thromboembolism:the Tromsø study
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014)
Impact of incident venous thromboembolism on risk of arterial thrombotic diseases
(Journal article; Tidsskriftartikkel; Peer reviewed, 2013-11-22)
BACKGROUND: Growing evidence supports an association between venous thromboembolism (VTE) and arterial thrombotic diseases (ie, myocardial infarction and ischemic stroke). We aimed to study the association between VTE and future arterial events and to determine the population attributable risk of arterial events by VTE in a large prospective cohort recruited from the general population. METHODS AND ...
Obesity measures and risk of venous thromboembolism and myocardial infarction
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014)
Red Cell Distribution Width Is Associated With Incident Myocardial Infarction in a General Population: The Tromsø Study
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014)
Venous thromboembolism increases the risk of atrial fibrillation: The tromsø study
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014)
Physical activity and risk of venous thromboembolism. The Tromsø Study
(Journal article; Tidsskriftartikkel; Peer reviewed, 2010)
Impact of prothrombotic genotypes on the association between family history of myocardial infarction and venous thromboembolism
(Journal article; Tidsskriftartikkel; Peer reviewed, 2019-05-24)
<i>Background</i>: Family history of myocardial infarction (FHMI) is known to increase the risk of venous thromboembolism (VTE).<p>
<p><i>Objectives</i>: To investigate the effect of prothrombotic genotypes on the association between FHMI and VTE in a case‐cohort recruited from a general population.<p>
<p><i>Methods</i>: Cases with a first VTE (<i>n</i> = 1493) and a subcohort (<i>n</i> = ...
Hyperglycemia, Assessed by HbA1c, and Future Risk of Venous Thromboembolism - The Tromsø Study
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014-03-05)
Background: Glycated hemoglobin (HbA1c), a marker of average plasma glucose
during the last 8-12 weeks, is associated with future risk of cardiovascular disease
(CVD) and all-cause mortality.
Objectives: To examine the association between hyperglycemia, assessed by
HbA1c, and future risk of VTE in a population based cohort.
Methods: HbA1c was measured in 16 156 unique subjects (25-87 years) ...
Serum osteoprotegerin and future risk of cancer and cancer-related mortality in the general population: the Tromsø study
(Journal article; Tidsskriftartikkel; Peer reviewed, 2014)
Hematocrit and risk of venous thromboembolism in a general population. The Tromso study
(Journal article; Tidsskriftartikkel; Peer reviewed, 2010)